KDNY Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 Aug 2023 @ 16:00):

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases...

Stats
Today's Volume	3.28M
Average Volume	2.04M
Market Cap	2.71B
EPS	$0 ( 2024-02-26 )
Next earnings date	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-12.47
ATR14	$0.453 (1.12%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-11	Thomas Dolca	Sell	13 300	Common Stock
2023-08-11	Thomas Dolca	Sell	23 522	Stock Option (Right to Buy)
2023-08-11	Thomas Dolca	Sell	5 948	Stock Option (Right to Buy)
2023-08-11	Thomas Dolca	Sell	13 300	Stock Option (Right to Buy)
2023-08-11	Oxtoby Andrew	Sell	160 000	Stock Option (Right to Buy)

INSIDER POWER
-96.00
Last 99 transactions
Buy: 289 232 \| Sell: 10 194 260

Volume Correlation

Long: 0.28 (neutral)

Short: 0.00 (neutral)

Signal:(78.495) Neutral

Aduro Biotech Inc Correlation

10 Most Positive Correlations
COLL	0.876
GLMD	0.873
BCDA	0.868
EVER	0.865
EEIQ	0.86
CNXC	0.86
ATIF	0.857
AGNC	0.856
ABIO	0.853
DADA	0.848

10 Most Negative Correlations
RMRM	-0.904
MTEK	-0.902
APR	-0.88
APP	-0.859
MMAC	-0.857
NGMS	-0.85
AAPL	-0.845
RBKB	-0.843
RIBT	-0.842
COUP	-0.841

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aduro Biotech Inc Correlation - Currency/Commodity

0.93
( very strong )

0.90
( strong )

-0.81
( strong negative )

0.84
( strong )

-0.33
( neutral )

-0.63
( weak negative )

Aduro Biotech Inc Financials

Annual	2022
Revenue:	$6.13M
Gross Profit:	$4.41M (71.90 %)
EPS:	$-2.87

FY	2022
Revenue:	$6.13M
Gross Profit:	$4.41M (71.90 %)
EPS:	$-2.87

FY	2021
Revenue:	$51 625.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.00226

FY	2020
Revenue:	$827 000
Gross Profit:	$827 000 (100.00 %)
EPS:	$-6.20

Financial Reports:

No articles found.

Aduro Biotech Inc

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.